P&G spends big in attempt to lead bone health - DrugResearcher.com
P&G spends big in attempt to lead bone healthDrugResearcher.com, France - Jul 4, 2007The first to be marketed in the US was AstraZeneca's Accolate (zafirlukast) around 10 years ago, but now others have also been approved, including Merck …
Read full story